HomeFATE • NASDAQ
Fate Therapeutics Inc
add
$1.00
5.26%
After Hours:(0.99%)+0.0099
$1.01
Closed: Sep 18, 6:04:32 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.91M | -71.84% |
Operating expense | 35.05M | -24.81% |
Net income | -34.07M | 11.34% |
Net profit margin | -1.79K | -214.85% |
Earnings per share | -0.29 | 12.12% |
EBITDA | -33.69M | 16.53% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 222.83M | -26.91% |
Total assets | 371.63M | -29.72% |
Total liabilities | 110.27M | -16.36% |
Total equity | 261.36M | — |
Shares outstanding | 115.33M | — |
Price to book | 0.42 | — |
Return on assets | -24.00% | — |
Return on capital | -25.87% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -34.07M | 11.34% |
Cash from operations | -24.59M | 23.89% |
Cash from investing | 19.59M | 136.71% |
Cash from financing | 1.33M | 4.00% |
Net change in cash | -3.67M | 95.65% |
Free cash flow | -12.41M | 56.27% |
Previous close
$0.95
Day range
$0.96 - $1.02
Year range
$0.66 - $4.20
Market cap
115.33M USD
Avg Volume
1.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2007
Website
Employees
181
